Charles Schwab
REPL icon

Charles Schwab’s Replimune Group REPL Stock Holding History

Charles Schwab’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.08M Buy
639,986
+28,227
+5% +$173K ﹤0.01% 2318
2026
Q1 		$4.68M Buy
611,759
+23,869
+4% +$182K ﹤0.01% 2428
2025
Q4 		$5.71M Buy
587,890
+72,490
+14% +$616K ﹤0.01% 2383
2025
Q3 		$2.16M Sell
515,400
-37,763
-7% -$241K ﹤0.01% 2729
2025
Q2 		$5.14M Buy
553,163
+1,117
+0.2% +$9.75K ﹤0.01% 2327
2025
Q1 		$5.38M Buy
552,046
+43,648
+9% +$540K ﹤0.01% 2241
2024
Q4 		$6.16M Buy
508,398
+23,601
+5% +$287K ﹤0.01% 2245
2024
Q3 		$5.31M Buy
484,797
+52,498
+12% +$533K ﹤0.01% 2347
2024
Q2 		$3.89M Buy
432,299
+13,635
+3% +$95K ﹤0.01% 2457
2024
Q1 		$3.42M Buy
418,664
+16,722
+4% +$137K ﹤0.01% 2431
2023
Q4 		$3.39M Buy
401,942
+23,632
+6% +$274K ﹤0.01% 2468
2023
Q3 		$6.47M Buy
378,310
+93,364
+33% +$1.83M ﹤0.01% 2130
2023
Q2 		$6.62M Sell
284,946
-11,707
-4% -$229K ﹤0.01% 2106
2023
Q1 		$5.24M Buy
296,653
+37,076
+14% +$882K ﹤0.01% 2184
2022
Q4 		$7.06M Buy
259,577
+7,337
+3% +$152K ﹤0.01% 2033
2022
Q3 		$4.36M Buy
252,240
+42,307
+20% +$807K ﹤0.01% 2286
2022
Q2 		$3.67M Sell
209,933
-5,914
-3% -$97.2K ﹤0.01% 2320
2022
Q1 		$3.67M Buy
215,847
+6,953
+3% +$131K ﹤0.01% 2420
2021
Q4 		$5.66M Buy
208,894
+3,638
+2% +$109K ﹤0.01% 2289
2021
Q3 		$6.08M Buy
205,256
+23,962
+13% +$778K ﹤0.01% 2276
2021
Q2 		$6.97M Buy
181,294
+7,575
+4% +$259K ﹤0.01% 2191
2021
Q1 		$5.3M Buy
173,719
+8,690
+5% +$325K ﹤0.01% 2274
2020
Q4 		$6.3M Buy
165,029
+29,272
+22% +$1.22M ﹤0.01% 2106
2020
Q3 		$3.13M Buy
135,757
+94,999
+233% +$2.16M ﹤0.01% 2310
2020
Q2 		$1.01M Buy
40,758
+8,264
+25% +$146K ﹤0.01% 2622
2020
Q1 		$324K Buy
32,494
+1,284
+4% +$19.1K ﹤0.01% 2860
2019
Q4 		$448K Buy
31,210
+3,548
+13% +$51.1K ﹤0.01% 2862
2019
Q3 		$385K Hold
27,662
– – ﹤0.01% 2902
2019
Q2 		$406K Hold
27,662
– – ﹤0.01% 2908
2019
Q1 		$422K Buy
27,662
+13,502
+95% +$168K ﹤0.01% 2823
2018
Q4 		$142K Hold
14,160
– – ﹤0.01% 3061
2018
Q3 		$228K Buy
+14,160
New +$248K ﹤0.01% 3060

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Charles Schwab's REPL Position: Q2 2026 in Review

Charles Schwab increased its Replimune Group (REPL) stake by 4.6% in Q2 2026, buying an estimated $173K and bringing the position to 639,986 shares worth $7.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2318.

Charles Schwab first reported a position in REPL in Q3 2018 and has held it in 32 quarters since. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Charles Schwab held 639,986 shares of Replimune Group worth $7.08M as of Q2 2026.
  • Charles Schwab bought 28,227 Replimune Group shares in Q2 2026, an estimated $173K.
  • Replimune Group made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2318 holding.
  • Charles Schwab first reported a position in Replimune Group in Q3 2018 and has held it in 32 quarters since.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.